CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

Evil Rabbit

07/18/2025 11:56:20 AM

If youre conducting some kind of (20)

Enjay

07/18/2025 11:35:40 AM

With regard to a possible class action (16)

Riztheinvestor

07/18/2025 9:07:50 AM

Well said The truth is already leaking. (4)

DJknows

07/18/2025 9:00:34 AM

While I agree with you Riz, it NEEDS (3)

Riztheinvestor

07/18/2025 8:52:27 AM

Lets be honest this is the real (19)

stevo180

07/18/2025 8:47:09 AM

I knew I saved this for a reason. Its a (5)

DJknows

07/18/2025 8:40:11 AM

As I see it, unless regulators and (5)

DJknows

07/18/2025 8:32:42 AM

Not my words that it would be messy... (3)

docj

07/18/2025 7:14:58 AM

"I believe our current strategy will (10)

Riztheinvestor

07/18/2025 2:07:14 AM

I have an open case on him as well. I (4)

chazzledazzle

07/17/2025 11:55:52 PM

Mr Feuerstein gets sued on average (2)

DJknows

07/17/2025 9:50:49 PM

I don't know if indeed it is true...

Boatbuilder

07/17/2025 8:18:21 PM

Double secret quiet period. (3)

FKAdamF.

07/17/2025 7:45:25 PM

Please let me know if thats true. I (13)

sean007

07/17/2025 7:22:41 PM

I would agree...the absence of (5)

cardamine

07/17/2025 7:15:06 PM

A company can *definitely* say they're (3)

Emmitt

07/17/2025 6:19:05 PM

Anyone here ever considered we might (2)

DJknows

07/17/2025 6:11:51 PM

Anyone hear about this potential (1)

Plotinus

07/17/2025 6:07:03 PM

I keep reminding myself that there is (8)

misiu143

07/17/2025 4:46:08 PM

I tried , 2 times , no response (2)

docj

07/17/2025 4:45:37 PM

Same here hoops. Tyler isn't a big fan (1)

Mr3Putt

07/17/2025 4:39:47 PM

Yes and no. :( (1)

hoops

07/17/2025 4:25:12 PM

I emailed IR twice to ask about the (9)

thriftycents

07/17/2025 3:54:53 PM

And creatv microtech, which caught my (5)

Jake2212

07/17/2025 3:52:59 PM

thriftycents: Merck and GSK are also (6)

Trimble

07/17/2025 2:23:23 PM

Extremely low trading volume today, (3)

My69z

07/17/2025 11:36:20 AM

Mgt has said only keeping oncology & (4)

Cycl2R

07/17/2025 10:49:47 AM

If this is true, it's disappointing to (1)

My69z

07/17/2025 9:09:28 AM

Woops ---That's 3: ......."In fact, the (4)

My69z

07/17/2025 9:05:52 AM

From Hiv publication Mar 31, 2022: "All (5)

brentie

07/17/2025 6:24:45 AM

GPCR Targeting Technologies: The Next (18)

Katangolo

07/17/2025 12:02:35 AM

Nah the SEC and FINRA at the very (5)

Riztheinvestor

07/16/2025 11:52:07 PM

Companies often finalize NDAs and LOIs (6)

Riztheinvestor

07/16/2025 11:46:46 PM

Ha I wish. (1)

Katangolo

07/16/2025 10:40:35 PM

We are on our way kids. Lots going on (13)

Katangolo

07/16/2025 10:36:35 PM

Truth (2)

thriftycents

07/16/2025 10:33:38 PM

I see your concern about the timeline. (5)

brentie

07/16/2025 10:14:57 PM

Well, someone's got to state the (5)

thriftycents

07/16/2025 9:56:33 PM

2025 BIO International Convention I (21)

My69z

07/16/2025 9:12:02 PM

card -- actually the 5 required in CRC (10)

sean007

07/16/2025 8:35:29 PM

You're getting paid on the (1)

Riztheinvestor

07/16/2025 8:08:33 PM

Im trying. 6 of the 12 have been

sean007

07/16/2025 7:56:10 PM

You're firing on all 12 today (3)

Riztheinvestor

07/16/2025 7:34:32 PM

Youre right theyre not the same (6)

Riztheinvestor

07/16/2025 7:31:31 PM

Agree and if the Cytodyn is smart they (2)

Riztheinvestor

07/16/2025 7:16:56 PM

What My69z Was Saying (But the Room (21)

Riztheinvestor

07/16/2025 7:05:42 PM

Lets just say someone already

My69z

07/16/2025 7:04:58 PM

"Weekly Leronlimab treatment in a (4)

sean007

07/16/2025 6:51:43 PM

The initial agreement was July (2)

Firelife619

07/16/2025 6:17:25 PM

Sean, it is to my understand that since (3)

Newer

Older

Recent Articles

• Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
• Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
• Google's Decision to Shift Women Techmakers Program Sparks Controversy
• Podiatry Content Connection Unveils Innovative AI Solutions
• zerohash Europe Gets MiCAR Authorization for Crypto Services
• Tech Titans' Dinner Sparks Fried Chicken Stock Boom
• The Rise of the Silver American Eagle: Why Stackers Are Going All In
• Tenaris Launches $600 Million in Share Buyback for Investors
• Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
• Tenaris Launches $600 Million in Share Buybacks Amid Growth
• Exploring AI Adoption Among Small Businesses Across The U.S.
• Shiba Inu ETF Filing Sparks Significant Token Burn Event
• Investors of Avantor, Inc. Encouraged to Seek Justice Together
• Al Salam Bank Commemorates ASB Capital's Successful Year
• Tom Lee: The Trusted Face of Ethereum in the Finance World
• Elon Musk and Sam Altman: The Roadster Refund Debate
• Navigating Career Transitions: Insights from Industry Experts
• Key Steps for Fortinet, Inc. Investors Ahead of Class Action
• Air Traffic Controllers Face Staffing Crisis Amid Shutdown
• Warren Challenges Trump on Rising Costs Affecting Families
• James Hardie Industries Investors Invited to Join Critical Lawsuit
• Fluor Corporation's Investors Encouraged to Act Now for Justice
• Bitcoin Surges to $100K Amidst Market Challenges and Insights
• Ziegler Successfully Completes $44M Financing for Frasier
• Lowe's Contributes $1 Million for Hurricane Recovery in Jamaica
• Celebrate Dodgers' Triumph with New Era's 2025 Collection
• Richmond Terrace Capital Launches New €1.5 Billion Investment Fund
• Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing
• Sequoia Capital Launches $950M Fund to Fuel AI Innovators
• Virginia Veterans Celebrate with Free Book Vouchers for Stories
• Innovative Advancements of Poain BlockEnergy in Global DeFi Market
• Investors of aTyr Pharma Should Secure Legal Help Now
• Bahrain Premieres Revolutionary Rooftop Solar Power Initiative
• Deqing's Pearl Mussel Award: A Mark of Agricultural Heritage
• Buck Sexton Unveils the Dawn of America’s Next Wealth Era
• Navigating the Promising Journey of Mutuum Finance and MUTM
• Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
• Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
• Top Stock Insights: Palantir's Surge and Pfizer's Struggles
• The Last Messages of Charlie Kirk Revealing His Fears
• Significant Stock Declines: Fiserv, eBay, and Garmin Under Pressure
• Major Moves in Tech: Earnings Reports & Market Trends Ahead
• Ford Faces Major Recall Challenges But Sees Opportunities Ahead
• Discover the Hidden Gems: Stocks Gaining Investor Interest
• OncoHost Showcases Innovative Insights in NSCLC Proteomics
• Mutuum Finance Gears Up for Exciting V1 Launch with $18M Raised
• Apple's Impressive Earnings, Bold Future Predictions Unveiled
• Fangzhou's Innovative AI Solutions Transform Chronic Care Management
• Fangzhou Innovates Chronic Disease Management with AI Solutions
• CoorsTek Bioceramics Triumphs in Legal Right to Market Hip Components